X-ray manufacturer Del Global Technologies posted what it calls the strongest fourth-quarter and fiscal-year results in its history. These 1998 figures are the result of a combination of internal revenue growth and a strong outsourcing trend by global
X-ray manufacturer Del Global Technologies posted what it calls the strongest fourth-quarter and fiscal-year results in its history. These 1998 figures are the result of a combination of internal revenue growth and a strong outsourcing trend by global medical equipment manufacturers.
For the year (end-August), Del reported net sales of $62.3 million, a 14% increase from the $54.7 million the company posted in 1997. Net income was $5.8 million, compared with the previous years $4.9 million.
Dels fourth-quarter revenues were also strong at $17.7 million, up 15% from $15.4 million in the fourth quarter of 1997. Net income for the period was $1.7 million, compared with $1.5 million the year before.
Medical imaging sales now contribute 80% of the Valhalla, NY, companys revenues, according to chief executive Leonard Trugman. The companys backlog stood at $36 million at year end.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.